Biology subjects

Mosler, T.

Publications and source records attributed to Mosler, T..

5 recordsLinked to original sources

bioRxiv2026

ProxiCapture Reveals Context-Dependent CRBN Interactore Landscape of Molecular Glue Degraders

Molecular glue degraders represent a rapidly expanding class of small molecules that reprogram E3 ubiquitin ligases to ubiquitinate and degrade disease-relevant proteins. Despite their therapeutic potential, the rational design of molecular glues remains challenging, underscoring the need for unbiased discovery strategies to identify new chemical targets. To address this challenge, we developed ProxiCapture, an affinity-based proteomics workflow that models the systemic behavior of molecular glues by combining purified CRBN-{Delta}HBD protein with native cell or tissue lysates. Systematic application of ProxiCapture across eight cancer cell lines, three maturation states of immune cells, and paired primary healthy and tumor tissues, revealed a comprehensive atlas of pomalidomide interactors, including previously uncharacterized targets. These findings reveal that degrader-dependent interactors of CRBN are context-dependent, requiring broad, physiologically and systemically anchored sampling to uncover the full "glueable" proteome. Taken together, this study establishes a scalable platform that accelerates molecular glue discovery by capturing cell- and tissue-specific recruitment profiles and predicting system-wide degrader effects.

cancer biology↗

bioRxiv2025

Ubiquitin-dependent signal amplification in lipid saturation sensing

Cellular membranes are dynamic platforms whose composition and biophysical properties are surveyed by sensor proteins to maintain homeostasis. Failure to preserve membrane homeostasis, however, results in cellular stress and organelle dysfunction. Using the prototypical lipid saturation sensor Mga2, we explored how weak physical cues that modulate rotational movements in the transmembrane region are converted into decisive biochemical outputs that ultimately control the production of unsaturated fatty acids. Quantitative in vitro ubiquitylation assays and kinetic modeling reveal vastly distinct rates of Mga2 ubiquitylation controlled by the membrane environment. Mga2 ubiquitylation dominates in tightly packed, saturated membranes, while loosely packed environments favor an inhibitory autoubiquitylation of the cognate E3 ligase Rsp5. This mechanism provides a means of signal amplification, which can function even in the absence of deubiquitylating enzymes. Our findings provide a mechanistic framework for how membrane property sensors convert weak, fluctuating physical cues into robust biochemical outcomes, and put a spotlight on the regulatory potential of E3 ligase autoubiquitylation in cellular surveillance.

biochemistry↗

bioRxiv2025

Loss of CTLH component MAEA impairs DNA repair and replication and leads to developmental delay

Ubiquitin E3 ligases play crucial roles in the DNA damage response (DDR) by modulating the turnover, localization, activation, and interactions of DDR and DNA replication proteins. To gain further insight into how the ubiquitin system regulates the DDR, we performed a CRISPR-Cas9 knockout screen focused on E3 ligases and related proteins with the DNA topoisomerase I inhibitor, camptothecin. This uncovered the CTLH ubiquitin E3 ligase complex -- and particularly one of its core subunits, MAEA -- as a critical regulator of the cellular response to single-ended DNA double-strand breaks (seDSBs) and replication stress. In tandem, we identified patients with variants in MAEA who present with neurodevelopmental deficits including global developmental delay, dysmorphic facial features, brain abnormalities, intellectual disability, and abnormal movement. Analysis of patient-derived cell lines and mutation modeling reveal an underlying defect in HR-dependent DNA repair and replication fork restart as a likely cause of disease. We propose that MAEA dysfunction hinders DNA repair by reducing the efficiency of RAD51 loading at sites of DNA damage, which compromises genome integrity and cell division during development.

genetics↗

bioRxiv2025

TRIM28 regulates pre-mRNA splicing via phosphorylation and SUMOylation networks

Pre-mRNA splicing is a highly regulated process orchestrated by splicing factors, cis-acting elements, and interconnected cellular processes such as transcription and chromatin remodeling. Here, we identify a novel regulatory axis involving phosphorylation and SUMOylation that governs the function of Tripartite motif-containing 28 protein (TRIM28) and its role in pre-mRNA splicing. We demonstrate that TRIM28 interacts with the spliceosomal protein USP39 in a phosphorylation-dependent manner, with non-phosphorylated TRIM28 promoting USP39 SUMOylation at defined lysine residues. This post-translational modification enhances USP39s role within the U4/U6.U5 tri-snRNP complex. Functionally, TRIM28 knockdown induces widespread alterations in alternative splicing patterns, underscoring its importance in splicing regulation. Together, our findings uncover a mechanistic link between TRIM28-mediated post-translational modifications and the modulation of spliceosomal activity, offering new insights into how splicing decisions are integrated with cellular signaling pathways.

cell biology↗

bioRxiv2024

Disruption of the epigenetic regulator BAP1 drives chromatin remodeling leading to the emergence of cells with breast cancer stem cell properties and aberrant glycosylation.

BackgroundEpigenetic regulator genes play critical roles in controlling cell identity and are frequently disrupted in breast cancers, suggesting a key driver role in this disease and its associated phenotypes. However, specific epigenetic drivers (epidrivers) of mammary cell plasticity and their mechanistic contributions to this phenotype are poorly characterized. MethodsTo identify potential epidrivers of the emergence of mesenchymal breast cancer stem cell-like phenotypes in non-tumorigenic mammary cells, we employed a CRISPR/Cas9 loss-of-function screening strategy targeting epigenetic regulator genes. This approach was followed by an in-depth validation and characterization of epigenomic, transcriptomic, proteomic and phenotypic changes resulting from the disruption of the putative epidriver gene BAP1. ResultsOur investigation revealed that loss of the histone deubiquitinase BAP1 impacts cellular processes associated with breast cancer cell plasticity such as epithelial-to-mesenchymal transition (EMT) and actin cytoskeleton organization. In addition, we unveiled that BAP1 loss resulted in an overall less permissive chromatin and downregulated gene expression, impacting programs that control cellular glycosylation and leading to decreased glycan abundance and complexity. BAP1 rescue restored the expression of several deregulated genes in a catalytic activity-dependent manner, suggesting that BAP1-mediated cell identity and glycosylation regulation are largely dependent on its histone deubiquitinase activity. ConclusionsOverall, our results point to BAP1 disruption as a driver of mammary cell plasticity and reveal a novel role of BAP1 as an epigenetic regulator of cellular glycosylation.

cancer biology↗